Acute administration of the GLP-1 receptor agonist, Exenatide, restores impaired central responses to food ingestion in type 2 diabetes

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)S100 - S100
JournalDiabetologia
Volume53
Publication statusPublished - 2010

Cite this